Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2) — Stella

Home/Pancreatic Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Pancreatic Cancer trials

Trial locations(1 site)

United Kingdom

Imperial College Healthcare NHS Trust, London

Key details

Sponsor

Imperial College London

Collaborators

Pancreatic Cancer UK, Imperial College Healthcare NHS Trust

Enrollment target

~6,079 participants

Started

October 2025

Primary completion

August 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.